TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · major macro event coming up
ANIP

ANI Pharmaceuticals Inc

Healthcare · Drug Manufacturers - Specialty & Generic

74.00$ -0.1% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Balance Sheet

ANI Pharmaceuticals Inc (ANIP) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 1,494 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet ANIP
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
890 904 915 921 1,287 1,284 1,292 1,343 1,408 1,440 1,422 1,494
497 520 541 555 521 528 536 603 698 753 747 825
193 221 229 240 145 145 150 218 263 286 311 360
193 221 238 247 153 151 155 224 263 286 311 376
179 162 172 166 196 222 220 226 253 281 255 274
107 111 114 125 148 137 137 138 146 143 143 143
28 28 28 28 60 60 61 61 62 62 62 62
220 209 196 183 570 542 538 520 500 480 467 450
435 472 463 440 857 855 849 881 902 900 860 897
134 145 137 140 190 194 202 237 271 278 240 284
0.9 0.9 0.9 0.9 7.2 9.2 11 13 15 17 19 21
34 37 49 49 61 46 53 55 70 63 70 74
285 285 285 284 618 615 612 608 605 600 594 589
455 433 452 481 431 429 443 462 506 541 562 597
-81 -80 -62 -65 -90 -100 -85 -77 -51 -23 6.4 31
19 19 19 19 19 19 20 20 21 21 22 22

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?